Publication details
Observační studie pacientů léčených lerkanidipinem v podmínkách běžné klinické praxe v České republice
| Title in English | Observational study of patients treated with lercanidipine in conditions of clinical practice in the Czech republic |
|---|---|
| Authors | |
| Year of publication | 2014 |
| Type | Article in Periodical |
| Magazine / Source | Kardiologická revue - Interní medicína |
| MU Faculty or unit | |
| Citation | |
| Field | Pharmacology and pharmaceutical chemistry |
| Keywords | lercanidipine; hypertension; oedemas; calcium ion channel inhibitors |
| Description | Lercanidipine is a calcium ion channel inhibitor that is used in the treatment of mild to moderate hypertension at dosages from 10 to 20mg. The authors of this article summarize its use in an observational trial performed in the Czech republic in 375 patients with essential arterial hypertension. It was demonstrated the achievement of primary endpoint, i.e. significantly decreased of blood pressure. This was accompanied by a relatively small change of heart rate and po¬sitive safety profile. |